PerkinElmer, Inc. (PKI) |
|
133.26 2.26 (1.73%)
|
03-31 16:03 |
|
Open: |
131.64 |
Pre. Close: |
131 |
|
High:
|
133.6 |
Low:
|
130.96 |
|
Volume:
|
589,316 |
Market Cap:
|
16,846(M) |
|
|
|
Technical analysis |
as of: 2023-03-31 4:21:18 PM |
|
Overall:
|
 |
| Stoxline posted a BUY today, same as yesterday. Upward movement continues. |
| Target: |
Six months: 156.04  One year: 182.26 |
| Support: |
Support1: 123.18 Support2: 116.75 |
| Resistance: |
Resistance1: 133.6 Resistance2: 156.04 |
| Pivot: |
126.11 |
| Moving Average: |
MA(5): 129.98 MA(20): 125.64
MA(100): 134.31 MA(250): 138.88  |
| MACD: |
MACD(12,26): 0.2 Signal(9): -1.1 |
| Stochastic oscillator: |
%K(14,3): 95.1 %D(3): 91.9 |
| RSI: |
RSI(14): 61.9 |
| 52-week: |
High: 174.1 Low: 113.45 |
| Average Vol(K): |
3-Month: 860 (K) 10-Days: 632 (K) |
|
Price, moving averages and Bollinger Bands |
|
Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BEARISH in mid-long term.[ PKI ] has closed Bollinger Bands are 2.2% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices. |
|
|
Stock Price Prediction |
Update at 5:00pm EST |
|
If tomorrow:
|
Open lower
|
Open higher
|
|
High:
|
133.68 - 134.08 |
134.08 - 134.52 |
|
Low:
|
130.09 - 130.57 |
130.57 - 131.12 |
|
Close:
|
132.4 - 133.14 |
133.14 - 133.96 |
|
Company Description |
|
PerkinElmer, Inc. provides products, services, and solutions to the diagnostics, life sciences, and applied services markets worldwide. It operates through two segments, Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment offers a suite of solutions, including reagents, informatics, and detection and imaging technologies that enable scientists to enhance research breakthroughs in the life sciences research market, as well as contract research and laboratory services. It also provides analytical technologies, solutions, and services for the environmental, food, and industrial markets that enable its customers to understand the characterize the health of various aspects, including air, water, and soil. In addition, this segment offers solutions to farmers and food producers; and analytical instrumentation for the industrial market, which includes the chemical, semiconductor and electronics, energy, lubricant, petrochemical, and polymer industries. The Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market. Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions. This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery. It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies. PerkinElmer, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts. |
Headline News |
Sat, 01 Apr 2023
Maxwell Krakowiak Sells 322 Shares of PerkinElmer, Inc. (NYSE:PKI ... - MarketBeat
Wed, 29 Mar 2023
PerkinElmer Inc. stock rises Wednesday, still underperforms market - MarketWatch
Mon, 27 Mar 2023
Should You Sell PerkinElmer, Inc. (PKI) Stock Monday? - InvestorsObserver
Tue, 21 Mar 2023
Will PerkinElmer, Inc. (PKI) Stay at the Bottom of the Healthcare Sector? - InvestorsObserver
Thu, 16 Mar 2023
PerkinElmer, Inc. (NYSE:PKI) Receives Average Rating of "Hold ... - MarketBeat
Wed, 15 Mar 2023
Is PerkinElmer, Inc. (PKI) a Stock to Watch After Losing -1.34% This Week? - InvestorsObserver
|
Financial Analysis |
| Price to Book Value: |
Outperform |
| P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
| Price to Earnings: |
Outperform |
| PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
| Discounted cash flow: |
Outperform |
| DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
| Return on Assets: |
Neutral |
| ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
| Return on Equity: |
Neutral |
| ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
| Debt to Equity: |
Outperform |
| evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
|
|
|
|
|
|
| Free Technical Analysis Charts
|
|
|
Stock Basics & Statistics |
| Exchange: NYSE |
| Sector: Healthcare |
| Industry: Diagnostics & Research |
| Shares Out. |
126 (M) |
| Shares Float |
116 (M) |
|
% Held by Insiders
|
0.2 (%) |
|
% Held by Institutions
|
85.6 (%) |
|
Shares Short
|
3,480 (K) |
|
Shares Short P.Month
|
3,070 (K) |
Stock Financials |
|
EPS
|
4.05 |
|
EPS Est Next Qtl
|
0.93 |
|
EPS Est This Year
|
2.88 |
|
EPS Est Next Year
|
3.26 |
|
Book Value (p.s.)
|
58.45 |
|
Profit Margin (%)
|
17.1 |
|
Operating Margin (%)
|
25.9 |
|
Return on Assets (ttm)
|
3.6 |
|
Return on Equity (ttm)
|
7 |
|
Qtrly Rev. Growth
|
-27.9 |
|
Gross Profit (p.s.)
|
16.13 |
|
Sales Per Share
|
26.18 |
|
EBITDA (p.s.)
|
10.2 |
|
Qtrly Earnings Growth
|
-32.5 |
|
Operating Cash Flow
|
680 (M) |
|
Levered Free Cash Flow
|
-262 (M) |
Stock Valuations |
|
PE Ratio
|
32.82 |
|
PEG Ratio
|
-3 |
|
Price to Book value
|
2.27 |
|
Price to Sales
|
5.08 |
|
Price to Cash Flow
|
24.77 |
Stock Dividends |
|
Dividend
|
0.07 |
|
Forward Dividend
|
0 |
|
Dividend Yield
|
0% |
|
Dividend Pay Date
|
2022-02-10 |
|
Ex-Dividend Date
|
2022-01-19 |
|
Your Ad Here
|
|
